The Discounted Cash Flow (DCF) valuation of Immunovia AB (publ) (IMMNOV.ST) is (5.58) SEK. With the latest stock price at 0.22 SEK, the upside of Immunovia AB (publ) based on DCF is -2695.3%.
Based on the latest price of 0.22 SEK and our DCF valuation, Immunovia AB (publ) (IMMNOV.ST) is a sell. selling IMMNOV.ST stocks now will result in a potential gain of 2695.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.8% - 6.4% | 5.6% |
| Long-term Growth Rate | 3.0% - 4.3% | 3.7% |
| Fair Price | (22.18) - (3.23) | (5.58) |
| Upside | -10417.2% - -1603.7% | -2695.3% |